Business
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, C...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"PharmaCielo Announces Revocation of FFCTO and Related Corporate MattersAll figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 30, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) (\"PharmaCielo\" or the \"Company\"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced revocation of FFCTO and related corporate matters.Reinstatement to TradingEffective October 27, 2025, PharmaCielo's principal regulator, the Ontario Securities Commission (\"OSC\"), has revoked the failure to file cease trade order (the \"FFCTO\") that was issued on August 5, 2025. The FFCTO resulted from a delay in filing the Company's audited annual consolidated financial statements for the fifteen months ended March 31, 2025, along with the related management's discussion and analysis and CEO/CFO certifications as required under National Instrument 52-109 - Certification of Disclosure in Issuers' Annual and Interim Filings (collectively, the \"Required Documents\")The Required Documents have now been filed on SEDAR+, and trading of PharmaCielo shares will resume on the TSX Venture Exchange (the \"Exchange\") following the dissemination of this news release.Management Commentary Marc Lustig, Chairman and CEO of PharmaCielo commented, \"With the filing of our financial statements and the lifting of the cease trade order, PharmaCielo is ready to move forward. Over the past year, our team has worked with focus and discipline to strengthen the balance sheet, streamline operations in Colombia, and align our commercial efforts with the growing demand for high-quality, ethically produced cannabis ingredients.As we look ahead, our priorities are clear: Build consistent export volumes, deepen relationships with our international partners, and selectively expand into markets where we can sustain profitability.\"Summary Financials - Second Quarter Ended September 30, 2025Six months ended(000's)September 30, 2025September 30, 2024Revenue $ 1,212$ 2,113Adjusted EBITDA* (Loss)$ (531)$ (2,218)Net Loss$ (2,687)$ (5,219)Net Loss per Share$ (0.014)$ (0.031) *Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). The term Adjusted EBITDA does ...